Previsioni di mercato per il trattamento dei disturbi da iperpigmentazione in Nord America fino al 2030 - Analisi regionale - per tipo di trattamento (cosmeceutico, terapia con luce o laser, microdermoabrasione, peeling chimici, crioterapia e altri), condizione (melasma, lentiggini solari, iperpigmentazione post-infiammatoria e altri) e utente finale (ospedali, centri dermatologici e altri)
L\'aumento della prevalenza del melasma alimenta il mercato del trattamento dei disturbi da iperpigmentazione in Nord America
Il melasma, una delle condizioni di iperpigmentazione più diffuse, è caratterizzato da macule simmetriche di colore da marrone chiaro a marrone scuro con bordi sul viso, in particolare su mento, labbro superiore, naso, fronte e guance. È prevalente tra le donne e le persone con carnagione scura. Le caratteristiche cliniche malare, mandibolare e centrofacciale sono comuni nel melasma. L\'esposizione al sole, le variazioni ormonali, la gravidanza, i fattori ereditari, i cosmetici e i medicinali sono stati tutti collegati allo sviluppo del melasma. Diversi studi hanno stimato che la prevalenza complessiva del melasma nella popolazione generale varia dall\'1% al 50%. Il 55-64% dei casi di melasma ha riportato una storia familiare della stessa condizione. Inoltre, una maggiore prevalenza è segnalata negli individui di origine est-asiatica e ispanica, nonché nei pazienti con fototipi cutanei Fitzpatrick elevati (da IV a VI); è anche più alta negli individui che vivono in luoghi che ricevono intense radiazioni UV.
La gravidanza è un\'altra causa comune di melasma. Questa condizione ha un impatto anche sulle donne che assumono contraccettivi orali e ormoni. I livelli di estrogeni, progesterone e ormone melanocita-stimolante normalmente aumentano durante il terzo trimestre di gravidanza, il che potrebbe essere un fattore. Secondo il National Center for Biotechnology Information (NCBI) nell\'agosto 2023, il melasma è più comune negli anni riproduttivi e raramente si verifica prima della pubertà; la condizione si verifica nel 15-50% delle donne incinte e la sua prevalenza varia dall\'1,5% al 33%, a seconda della popolazione in una diversa regione. Pertanto, un aumento della prevalenza del melasma innesca la domanda di trattamenti per l\'iperpigmentazione.
Panoramica del mercato dei trattamenti per i disturbi da iperpigmentazione in Nord America
Il mercato dei trattamenti per i disturbi da iperpigmentazione in Nord America è segmentato in Stati Uniti, Canada e Messico. Gli Stati Uniti hanno detenuto la più grande quota di mercato dei trattamenti per i disturbi da iperpigmentazione in Nord America nel 2023. Secondo lo Skin of Color Update 2024 (una conferenza di dermatologia), la demografia degli Stati Uniti si sta evolvendo con la crescita della diversità etnica e razziale guidata dalla migrazione internazionale di ispanici, popolazioni asiatiche e africani nel paese, che probabilmente porterà anche a uno spostamento da minoranza a maggioranza intorno all\'anno 2050 verso individui con tipi di pelle Fitzpatrick III, IV, V e VI. In particolare, si prevede che la popolazione ispanica sarà tra i gruppi demografici in più rapida crescita negli Stati Uniti, con una crescita stimata da 55 milioni nel 2014 a 119 milioni nel 2060. Un tipo di pelle scura è più incline ai disturbi da iperpigmentazione.
Il numero di procedure estetiche negli Stati Uniti è aumentato in modo significativo negli ultimi 10 anni. Secondo l\'International Society of Plastic Surgeons (ISAPS), il numero di procedure estetiche non chirurgiche è aumentato del 19,9% nel 2021 rispetto al 2020 a livello globale. Il trattamento con luce pulsata intensa (IPL) è tra le prime 5 procedure cosmetiche minimamente invasive e nel 2020 sono state eseguite negli Stati Uniti circa 827.000 procedure IPL. Pertanto, è probabile che i progressi tecnologici nelle procedure non invasive avvantaggeranno ulteriormente il mercato del trattamento dei disturbi da iperpigmentazione negli Stati Uniti. A marzo 2023, la Food and Drug Administration (FDA) statunitense ha autorizzato il laser PicoWay di Candela Corporation per il trattamento di caffellatte, melasma, lentiggini e nevo di Ota. In precedenza, il sistema laser era stato approvato per il trattamento di lesioni pigmentate benigne, cicatrici da acne, rughe e rimozione di tatuaggi, tra le altre indicazioni.
Pertanto, fattori come la crescente diversità etnica e razziale e lo sviluppo di procedure estetiche mediche non invasive come cosmeceutici, peeling chimici, crioterapia, luce o terapia laser contribuiscono alla crescita del mercato del trattamento dei disturbi da iperpigmentazione negli Stati Uniti.
Entrate e previsioni del mercato del trattamento dei disturbi da iperpigmentazione in Nord America fino al 2030 (milioni di $ USA)
Segmentazione del mercato del trattamento dei disturbi da iperpigmentazione in Nord America
Il mercato del trattamento dei disturbi da iperpigmentazione in Nord America è suddiviso in tipo di trattamento, condizione, utente finale e paese.
In base al tipo di trattamento, il mercato del trattamento dei disturbi da iperpigmentazione in Nord America è segmentato in cosmeceutica, terapia con luce o laser, microdermoabrasione, peeling chimici, crioterapia e altri. Il segmento cosmeceutico ha detenuto la quota di mercato più grande nel 2022.
In base alla condizione, il mercato del trattamento dei disturbi da iperpigmentazione in Nord America è segmentato in melasma, lentiggini solari, iperpigmentazione post-infiammatoria e altri. Il segmento melasma ha detenuto la quota di mercato più grande nel 2022.
In base all\'utente finale, il mercato del trattamento dei disturbi da iperpigmentazione in Nord America è segmentato in ospedali, centri dermatologici e altri. Il segmento ospedali ha detenuto la quota di mercato più grande nel 2022.
Per paese, il mercato del trattamento dei disturbi da iperpigmentazione in Nord America è segmentato in Stati Uniti, Canada e Messico. Nel 2022 gli Stati Uniti hanno dominato la quota di mercato del trattamento dei disturbi da iperpigmentazione in Nord America.
AbbVie Inc, Bayer AG, Galderma SA, L\'OREAL SA, Lutronic Co Ltd, Obagi Cosmeceuticals LLC e Vivier Pharma Inc sono alcune delle aziende leader che operano nel mercato del trattamento dei disturbi da iperpigmentazione in Nord America.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Melasma
4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
4.2.1 High Cost of Treatments
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Use of Ablative Lasers
4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:
5. Hyperpigmentation Disorder Treatment Market - North America Analysis
5.1 North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
6. North America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type
6.1 Cosmeceutical
6.1.1 Overview
6.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
6.2.1 Overview
6.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
6.3.1 Overview
6.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
6.4.1 Overview
6.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
6.5.1 Overview
6.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Hyperpigmentation Disorder Treatment Market Analysis - by Condition
7.1 Melasma
7.1.1 Overview
7.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
7.2.1 Overview
7.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
7.3.1 Overview
7.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Hyperpigmentation Disorder Treatment Market Analysis - by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
8.2.1 Overview
8.2.2 Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Hyperpigmentation Disorder Treatment Market - Country Analysis
9.1 North America Hyperpigmentation Disorder Treatment Market
9.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.2 US
9.1.1.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.4 Canada
9.1.1.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.6 Mexico
9.1.1.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10. Hyperpigmentation Disorder Treatment Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 AbbVie Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Galderma SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Lutronic Co Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 L'OREAL S.A.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Pierre Fabre SA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Vivier Pharma Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Number of Laser-Based Nonsurgical Procedures Performed, 2020
Table 7. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 8. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 9. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 10. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 11. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 12. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 14. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 15. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 16. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 17. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 18. Glossary of Terms, Hyperpigmentation Disorder Treatment Market
List of Figures
Figure 1. North America Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 6. Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 13. Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 18. Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 22. North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Hyperpigmentation Disorder Treatment Market
- AbbVie Inc
- Bayer AG
- Galderma SA
- L'OREAL S.A.
- Lutronic Co Ltd
- Obagi Cosmeceuticals LLC
- Vivier Pharma Inc
- Pierre Fabre Group
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hyperpigmentation disorder treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America hyperpigmentation disorder treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.